Camrelizumab combined with chemotherapy followed by maintenance camrelizumab and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II, single-arm, exploratory study.
Glofitamab plus gemcitabine and oxaliplatin (Glofit-GemOx) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 2-year (yr) follow-up of STARGLO. Efficacy and safety ...
A retrospective cohort study in Veterans with cirrhosis found that giving intravenous albumin after outpatient paracentesis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results